SUPN Supernus Pharmaceuticals
- 36.920
- +0.490+1.35%
- 36.920
- 0.0000.00%
Supernus Pharmaceuticals News
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Rubin Jonathan
Supernus Pharmaceuticals | 8-K: Current report
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bhatt Padmanabh P.
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.25%),Steven Boyd(9.25%)
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director NEWHALL CHARLES W III
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mottola Frank
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Khattar Jack A.
Supernus Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director GEMAYEL GEORGES
Supernus Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
No Data